Abstract
The prognostic value of morphological classifications and clinical variables was compared between 31 elderly (≥65 years) and 43 young (<65 years) patients with myeloma. Prognostic factors were divided into three groups: factors useful in elderly patients, e.g., calcium, albumin; factors useful in young patients, e.g., platelet, creatinine, light-chain type; and factors useful in both patients, e.g., clinical stage, hemoglobin, LDH, CRP, bone marrow plasma cell and plasmablast percentages, light- and electron-microscopic classifications. The 5-year survival rates of elderly patients with calcium <12 and ≥12 mg/dl were 66.2 and <11.1%, respectively (p<0.01). Those of the young patients were 64.1 and 33.3%, respectively. The 5-year survival rates of elderly patients with platelets ≥200×109/l and <100×109/l were 59.7 and 50.0%, respectively. Those of the young patients were 68.9 and 33.3%, respectively (p<0.05). The 5-year survival rates of elderly patients with few and numerous electron-microscopic abnormalities were 90 and 0%, respectively (p<0.01), those of young patients were 92.9 and <14.3%, respectively (p<0.01). These findings suggest that individual clinical variables may differ in prognostic importance in elderly and young patients.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: March 11, 1998 · Accepted: September 14, 1998
Rights and permissions
About this article
Cite this article
Kurabayashi, H., Kubota, K., Tsuchiya, J. et al. Prognostic value of morphological classifications and clinical variables in elderly and young patients with multiple myeloma. Ann Hematol 78, 19–23 (1999). https://doi.org/10.1007/s002770050466
Issue Date:
DOI: https://doi.org/10.1007/s002770050466